Each mL of OvaMedTM (altrenogest) Solution 0.22% contains 2.2 mg of altrenogest in an oil solution.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indications
OvaMed™ is indicated for the suppression of estrus in mares. Suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal.
Benefits
- Attainment of regular cyclicity during the transition from winter anestrus to the physiological breeding season
- Management of prolonged estrus conditions
- Scheduled breeding during the physiological breeding season
Withdrawal Period
Do not use in horses intended for human consumption.
Additional Safety Information
Contraindications: Do not use in mares having a previous or current history of uterine inflammation (i.e., acute, subacute, or chronic endometritis). Natural or synthetic gestagen therapy may exacerbate existing low-grade or 'smoldering' uterine inflammation into a fulminating uterine infection in some instances.
Warnings and Precautions:
User Safety Warnings:
Avoid skin contact. OvaMed is absorbed through unbroken skin, and exposure may result in serious side effects to both women and men. Wear vinyl, neoprene or nitrile gloves when handling or administering, or when touching contaminated or equipment. Latex gloves are not protective.
PREGNANT WOMEN OR WOMEN WHO MAY BECOME PREGNANT SHOULD NOT HANDLE OVAMED. WOMEN OF CHILDBEARING AGE SHOULD EXERCISE EXTREME CAUTION WHEN HANDLING THIS PRODUCT.
Animal Safety Warnings and Precautions:
Various synthetic progestins, including altrenogest, when administered to rats during the embryogenic stage of pregnancy at doses many fold greater than the recommended equine dose caused fetal anomalies, specifically masculinization of the female genitalia.
For complete safety information, including those who should not handle OvaMed, please read product label or Data Sheet .
Pack Size
| List No. | Pack Size | Case Size |
|---|---|---|
| 1OVA007 | 1000 mL | 12 |